Intranasal insulin improves mitochondrial function and attenuates motor deficits in a rat 6‐OHDA model of Parkinson's disease

AIMS: Experimental and clinical evidences demonstrate that common dysregulated pathways are involved in Parkinson’s disease (PD) and type 2 diabetes. Recently, insulin treatment through intranasal (IN) approach has gained attention in PD, although the underlying mechanism of its potential therapeuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Iravanpour, Farideh, Dargahi, Leila, Rezaei, Mohsen, Haghani, Masoud, Heidari, Reza, Valian, Neda, Ahmadiani, Abolhassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871791/
https://www.ncbi.nlm.nih.gov/pubmed/33497031
http://dx.doi.org/10.1111/cns.13609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871791/
https://www.ncbi.nlm.nih.gov/pubmed/33497031
http://dx.doi.org/10.1111/cns.13609

Ejemplares similares